These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 17603558

  • 1. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
    Wang Y, Zhang ZG, Rhodes K, Renzi M, Zhang RL, Kapke A, Lu M, Pool C, Heavner G, Chopp M.
    Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, Pinto RM, Sepodes BM, Mota-Filipe HD.
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [Abstract] [Full Text] [Related]

  • 3. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
    Adembri C, Massagrande A, Tani A, Miranda M, Margheri M, De Gaudio R, Pellegrini-Giampietro DE.
    Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
    [Abstract] [Full Text] [Related]

  • 4. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ.
    Neurosci Lett; 2005 Oct 14; 387(1):5-10. PubMed ID: 16054296
    [Abstract] [Full Text] [Related]

  • 5. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
    Wang R, Wu X, Liang J, Qi Z, Liu X, Min L, Ji X, Luo Y, Zhao H.
    Int J Neurosci; 2015 Oct 14; 125(9):693-702. PubMed ID: 25226558
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X.
    Neurosci Lett; 2007 Oct 02; 425(3):177-82. PubMed ID: 17825990
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.
    Lapchak PA, Kirkeby A, Zivin JA, Sager TN.
    Brain Res; 2008 Oct 31; 1238():208-14. PubMed ID: 18761001
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotection with or without erythropoiesis; sometimes less is more.
    Torup L.
    Br J Pharmacol; 2007 Aug 31; 151(8):1141-2. PubMed ID: 17533424
    [Abstract] [Full Text] [Related]

  • 9. Decrease in Oxidative Stress Parameters after Post-Ischaemic Recombinant Human Erythropoietin Administration in the Hippocampus of Rats Exposed to Focal Cerebral Ischaemia.
    Mršić-Pelčić J, Pilipović K, Pelčić G, Vitezić D, Župan G.
    Basic Clin Pharmacol Toxicol; 2017 Dec 31; 121(6):453-464. PubMed ID: 28639431
    [Abstract] [Full Text] [Related]

  • 10. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A, Torup L, Bochsen L, Kjalke M, Abel K, Theilgaard-Monch K, Johansson PI, Bjørn SE, Gerwien J, Leist M.
    Thromb Haemost; 2008 Apr 31; 99(4):720-8. PubMed ID: 18392330
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin and Its Derivates Modulate Mitochondrial Dysfunction after Diffuse Traumatic Brain Injury.
    Millet A, Bouzat P, Trouve-Buisson T, Batandier C, Pernet-Gallay K, Gaide-Chevronnay L, Barbier EL, Debillon T, Fontaine E, Payen JF.
    J Neurotrauma; 2016 Sep 01; 33(17):1625-33. PubMed ID: 26530102
    [Abstract] [Full Text] [Related]

  • 12. A neuroprotective derivative of erythropoietin that is not erythropoietic.
    Doggrell SA.
    Expert Opin Investig Drugs; 2004 Nov 01; 13(11):1517-9. PubMed ID: 15500399
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
    Xu J, Culman J, Blume A, Brecht S, Gohlke P.
    Stroke; 2003 May 01; 34(5):1287-92. PubMed ID: 12677021
    [Abstract] [Full Text] [Related]

  • 14. Spinal Stroke: Outcome Attenuation by Erythropoietin and Carbamylated Erythropoietin and Its Prediction by Sphingosine-1-Phosphate Serum Levels in Mice.
    Koepke LG, Schwedhelm E, Ibing W, Oberhuber A, Daum G, Vcelar B, Schelzig H, Simon F.
    Int J Mol Sci; 2022 Aug 23; 23(17):. PubMed ID: 36076955
    [Abstract] [Full Text] [Related]

  • 15. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J, Nguyen-Ngoc M, Glatz T, Gohlke P, Herdegen T, Zhao Y.
    Exp Neurol; 2012 Dec 23; 238(2):243-53. PubMed ID: 22995601
    [Abstract] [Full Text] [Related]

  • 16. Erythropoietin delivered via intra-arterial infusion reduces endoplasmic reticulum stress in brain microvessels of rats following cerebral ischemia and reperfusion.
    Zhao H, Wang R, Wu X, Liang J, Qi Z, Liu X, Min L, Ji X, Luo Y.
    J Neuroimmune Pharmacol; 2015 Mar 23; 10(1):153-61. PubMed ID: 25626440
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin preconditioning improves clinical and histologic outcome in an acute spinal cord ischemia and reperfusion rabbit model.
    Simon FH, Erhart P, Vcelar B, Scheuerle A, Schelzig H, Oberhuber A.
    J Vasc Surg; 2016 Dec 23; 64(6):1797-1804. PubMed ID: 26610640
    [Abstract] [Full Text] [Related]

  • 18. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
    Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L.
    J Cereb Blood Flow Metab; 2007 Mar 23; 27(3):552-63. PubMed ID: 16835629
    [Abstract] [Full Text] [Related]

  • 19. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.
    Brain Res; 2009 May 19; 1271():121-7. PubMed ID: 19332033
    [Abstract] [Full Text] [Related]

  • 20. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P, Le Béhot A, ElAli A, Rivest S.
    Oncotarget; 2016 Jun 14; 7(24):35552-35561. PubMed ID: 27248662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.